Treatment with NPRA inhibitors, such as plasmid-encoded iNPRA NP73-102, significantly reduced the tumor load of mouse transplanted tumors and was accompanied by downregulation of NPRA and MIF expression. The gene discussed is NPR1; the disease is neoplasm.